This site is intended only for the use of Canadian Healthcare Professionals

Choose language:

Open Search
Open Menu

The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study

placeholder

This secondary analysis of the OPTIWIN study aimed to explore the differential effects of Optifast (total and partial meal replacement program), compared with a low-calorie food-based dietary plan, on atherosclerotic cardiovascular disease risk factors in adults with obesity.

Ard JD, et al. The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study. Diabetes Obes Metab. 2024;26(3):950-960.

This site is intended only for Canadian healthcare professionals. The products discussed in this site may have different product labeling in different countries.
In the event of a discrepancy between website information and product packaging, please refer to product packaging.
The information provided is for educational purposes only.

All trademarks are owned by Société des Produits Nestlé S.A., Vevey, Switzerland and used under license. ©2023 Nestlé.